(Total Views: 352)
Posted On: 04/22/2019 8:15:10 AM
Post# of 154931
Yes,
" CCL5 and CCR5 were regarded as poor prognosis signature marker in various cancer types "
And thanks to Dr Pestell , who most probably will have Nobel Price one day for his work in CCR5 , .. and Dr NP with his hard work to bring Leronlimab to what it is today .....we will accomplish something very positive soon here for those patients .....
IMO of course....
" CCL5 and CCR5 were regarded as poor prognosis signature marker in various cancer types "
And thanks to Dr Pestell , who most probably will have Nobel Price one day for his work in CCR5 , .. and Dr NP with his hard work to bring Leronlimab to what it is today .....we will accomplish something very positive soon here for those patients .....
IMO of course....
(0)
(0)
